Target intelligence / Profile preview

Bacillus cereus (B. cereus)

Target
B. cereus
Molecular classification
Biological Pathogen, Gram-positive Bacteria, Spore-forming Bacteria
01

Overview

Bacillus cereus is a Gram-positive, rod-shaped, spore-forming bacterium found ubiquitously in the environment [1]. It is primarily recognized as a significant cause of food poisoning, manifesting as either an emetic syndrome caused by the heat-stable toxin cereulide or a diarrheal syndrome mediated by heat-labile enterotoxins [1][2]. In addition to gastrointestinal issues, it is an opportunistic pathogen capable of causing severe non-gastrointestinal infections such as endophthalmitis, bacteremia, and meningitis, particularly in neonatal or immunocompromised populations [1][3]. Pharmacologically, B. cereus is notoriously resistant to most beta-lactam antibiotics, including penicillins and cephalosporins, due to the expression of multiple beta-lactamases [3][4]. Effective treatment regimens typically involve the use of vancomycin, clindamycin, or aminoglycosides [1][4]. The ability of the organism to form highly resilient endospores allows it to survive extreme environmental conditions like pasteurization and chemical disinfectants, posing a persistent challenge in both food safety and clinical sterilization protocols [2][5].

Other names
B. cereusBacillus cereus group (sensu stricto)
02

Mechanism of action

Antibiotics targeting Bacillus cereus work through various mechanisms including the inhibition of cell wall synthesis (e.g., Vancomycin), the inhibition of protein synthesis (e.g., Gentamicin, Clindamycin), or the inhibition of DNA gyrase activity (e.g., Ciprofloxacin) [1][4].

03

Biological functions

Toxin production (Cereulide, Enterotoxins)Endospore formationBiofilm formationBacterial metabolismMotility
04

Disease associations

Food poisoning (Emetic and Diarrheal)EndophthalmitisSepsisPneumoniaMeningitisInfection
05

Safety considerations

Intrinsic resistance to beta-lactam antibioticsPersistence of spores in medical and food processing environmentsRapidly destructive progression of ocular infectionsRisk of fulminant sepsis in immunocompromised hosts
06

Interacting drugs

Vancomycin

5 more in the full profile.

07

Biomarkers

Cereulide (emetic toxin)Hemolysin BL (Hbl)Non-hemolytic enterotoxin (Nhe)Cytotoxin K (CytK)16S ribosomal RNA sequencingCulture growth on MYP (Mannitol Egg Yolk Polymyxin) agar

Beyond the preview

Go deeper on Bacillus cereus (B. cereus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacillus cereus (B. cereus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call